Physician profile
Alfonso Barrera
NPI 1205865391
$24,037.64
in general payments reported to CMS, 2019-2025
17 companies · $595 in 2025
The $595 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $10K · 2021: $9,091 · 2022: $852 · 2023: $971 · 2024: $1,527 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,092.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $18,918.81 | 2019-2022 | |
| Mentor Worldwide LLC | $1,446.25 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Allergan, INC. | $917.42 | 2019-2022 | |
| Abbvie INC. | $538.99 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Motiva USA, LLC | $414.38 | 2024-2025 | |
| Sientra, INC. | $331.38 | 2019-2022 | |
| Axogen | $292.92 | 2020-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Musculoskeletal Transplant Foundation INC. | $257.70 | 2024-2025 | |
| Davol INC. | $227.40 | 2019 | |
| Tela Bio, INC. | $166.55 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $157.88 | 2023 | Durasorb Monofilament Mesh |
| Ethicon US, LLC | $116.42 | 2024 | Stratafix, Vistaseal, Surgicel Nu-Knit |
| Coopersurgical, INC. | $100.95 | 2020 | |
| Rti Surgical, INC | $67.30 | 2022 | |
| Vertical Pharmaceuticals, LLC | $34.66 | 2024 | Dsuvia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $24.63 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.00 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfonso Barrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.